SABER for life saving: dynamic peptide hydrogels as a frontier in long-acting therapeutics

Hydrogels are among the most intensively studied biomaterials for controlled drug delivery, yet translation to routine clinical practice has been limited by rapid diffusion of small molecules and instability of biologics. In their recent report in Nature Nanotechnology (Pogostin et al., 2025, DOI: 10.1038/s41565-025-01981-6), a team from Rice University and collaborators present a nanofibrous supramolecular peptide hydrogel system that addresses these challenges through the incorporation of dynamic covalent chemistry. The SABER (Self-Assembling Boronate Ester Release) platform introduces reversible boronate ester bonds between engineered peptide fibers and boronic acid modified therapeutics, creating a tunable and long-acting drug release system. Proof-of-concept applications included tuberculosis therapy, diabetes management, and prolonged antibody delivery, demonstrating both versatility and clinical relevance. In this Commentary, I situate this advance within the broader trajectory of hydrogel research, highlight the conceptual novelty of dynamic supramolecular interactions, and discuss the opportunities and challenges for clinical translation. I argue that this platform signals a paradigm shift in drug delivery, moving hydrogels from passive depots to dynamic partners in medicine.